When the World Health Organization reports that more than 57 million people live with dementia and nearly 10 million new cases emerge each year, I do not see an abstract statistic. I see families absorbing a crisis that governments still treat as a distant concern. In the United States, the Alzheimer’s Association estimates that 7.4 million Americans have Alzheimer’s and predicts dementia care will cost $409 billion in 2026 and nearly $1 trillion annually by 2050.
Waiting for that future is not a strategy, in my view. What frustrates me is that America already has a framework for a coordinated response. The Department of Health and Human Services’ National Plan to Address Alzheimer’s disease establishes goals spanning research, treatment, care, family support, public awareness, data, and risk reduction.
In 2024, Public Law 118-92 extended the National Alzheimer’s Project through 2035. It seems to me our failure is therefore not a lack of ideas or authority. It is accepting broad commitments without demanding measurable results.
The Government Accountability Office reinforced my concern in June 2026. It found that the Department of Health and Human Services still needed near-term goals with numerical targets, deadlines, and clearer progress reporting. You would have thought that finding should end the era of reassuring declarations.
We know dementia matters. Families plainly deserve to know who owns each goal, how success will be measured, and when results are due. I believe an effective strategy must connect three priorities: reducing risk, supporting care, and advancing treatment.
Treating them as separate agendas must weaken all three. Earlier detection risks being wasted if families cannot navigate care. Scientific progress will potentially reach too few people if there is a lag between diagnostic capacity and treatment access.
Extract — continue reading at the source.
